M
Masaharu Hashimoto
Researcher at Kurume University
Publications - 4
Citations - 323
Masaharu Hashimoto is an academic researcher from Kurume University. The author has contributed to research in topics: Hepatocellular carcinoma & Antigen. The author has an hindex of 4, co-authored 4 publications receiving 321 citations.
Papers
More filters
Journal ArticleDOI
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
Kunio Okuda,Yasuhiko Kubo,Nobuo Okazaki,Tsuneaki Arishima,Masaharu Hashimoto,Shigenobu Jinnouchi,Yasuhiko Sawa,Yutaka Shimokawa,Yukio Nakajima,Takehide Noguchi,Masayuki Nakano,Masamichi Kojiro,Toshiro Nakashima +12 more
TL;DR: The clinical features of 57 autopsied cases of intrahepatic bile duct carcinoma including 28 cases of the peripheral type (cholangiocarcinoma in the narrow sense) and 29 cases ofThe hilar type are described in comparison with those of hepatocellular carcinoma, with a review of the literature on the clinicopathological aspects.
Journal ArticleDOI
Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
Yutaka Shimokawa,Kunio Okuda,Yasuhiko Kubo,Akira Kaneko,Tsuneaki Arishima,Eisuke Nagata,Masaharu Hashimoto,Yasuhiko Sawa,Yoshikazu Nagasaki,Masamichi Kojiro,Kazuyoshi Sakamoto,Toshiro Nakashima +11 more
TL;DR: Of the five enzymes, SGOT changes were more closely correlated with the growth of HCC; SGPT reflected more of the liver parenchymal damage while SGOT was probably accounted for in part by tumor‐derived GOT.
Journal ArticleDOI
Localized submassive liver cell necrosis as a terminal event of liver carcinoma.
Kunio Okuda,Hirotaka Musha,Harushige Kanno,Masahiko Igarashi,Masayuki Nakano,Yutaka Shimokawa,Y. Kubo,Tsuneaki Arishima,Masaharu Hashimoto,Eisuke Nagata,Masamichi Kojiro,Kazuyoshi Sakamoto,Toshiro Nakashima +12 more
TL;DR: Six cases of hepatocellular carcinoma (HCC) and one case of metastatic liver carcinoma in which SGOT, SGPT, and SLDH were suddenly and markedly elevated immediately before death are described.
Journal ArticleDOI
Hepatitis B Surface Antigenemia in Patients with Hepatocellular Carcinoma in Relation to Clinical Course and α-Fetoprotein
Yasuhiko Kubo,Kunio Okuda,Yutaka Shimokawa,Tsuneaki Arishima,Eisuke Nagata,Masaharu Hashimoto,Shigenobu Jinnouchi,Yasuhiko Sawa,Hiroshi Obata,Naoaki Hayashi +9 more
TL;DR: Hepatitis B surface antigen was determined in sera of 122 cases of hepatocellular carcinoma seen in Japan, using both the counterimmunoelectrophoresis and radioimmunoassay techniques, and the degree of antigenemia, was increased during the clinical course in 75% of the patients.